Hawking's Universe Tipped To Win Aventis PrizesJune 17, 2002Stephen Hawking's The Universe in a Nutshell, sequel to the best-selling A Brief History of Time is tipped to win the General Prize of the Aventis Prizes for Science Books 2002. William Hill announced odds on the Prize - the scientific community's answer to the Booker Prize - placing Professor Hawking's book ahead of a strong list of contenders. The shortlist was selected from 83 entries submitted this year for the General Prize. The odds on the six contenders for the £10,000 Prize are: THE UNIVERSE IN A NUTSHELL
The judging panel for the General Prize is chaired by Dr Raj Persaud (Consultant Psychiatrist and Senior Lecturer at the Maudsley Hospital); Clive Cookson (Science Editor, The Financial Times); The Rt Reverend Dr Peter Forster (Bishop of Chester); Dr Janna Levin (Author and Advanced Fellow in the Department of Applied Mathematics and Theoretical Physics at Cambridge University) and Dr Robin Lovell-Badge (Head of the Division of Developmental Genetics at the MRC National Institute for Medical Research). They will meet on June 25, 2002 to decide the winner. The winners will be announced at a gala awards dinner for the Junior and General Prizes at the Science Museum, London on Tuesday, 25 June 2002. Each prize is worth £10,000 to the winning authors and £1,000 to each of the other shortlisted authors. - End - Copus - the Science Communication Partnership - is the national umbrella body for organisations and individuals involved in communicating science. Copus established and organises the Aventis Prizes for Science Books as part of its commitment to improving connections between science and its public audiences. The Prizes are part of its portfolio of activities to strengthen the agenda for science communication in all its forms. Other projects include grant schemes, working parties, workshops and publications. For further information see www.copus.org.uk. Copus is hosted by The Royal Society. Aventis Pharma is dedicated to treating and preventing human disease through discovery, development, manufacture and sale of innovative pharmaceutical products aimed at satisfying unmet medical needs. Aventis Pharma focuses on important therapeutic areas, such as cardiology, oncology, infectious diseases, arthritis, allergies and respiratory disorders, diabetes and central nervous system disorders. | |||||||||||||||||||||
Science Research Departments
Earth Science Alternative Energy | Anthropology and Archaeology | Earthquakes and Volcanoes | Environment and Nature News | Global Warming | High-Energy and Particle Physics | Ozone Hole | Scientists Slow Light | Tsunami Space Science Astronomy and Space News | Black Holes | Chandra X-Ray Observatory | Extrasolar Planets | Hubble Telescope | International Space Station | Jupiter Galileo Mission | Jupiter Cassini Mission Flyby | Mars Exploration | Mars Odyssey 2001 | Mars Global Surveyor | Mars Polar Lander | Mars Climate Orbiter | Mars Pathfinder | Meteors and Asteroids | Mir Space Station | NEAR Asteroid Probe Mission | Pluto Planet Debate | Search for Extraterrestrial Life | Space Shuttle Program | Space Shuttle Mission: STS-102 | Space Weather Life Science Animal News | Biotechnology and Genetics | Brain Research | Human Cloning | Dinosaur and Fossil Discoveries | Endangered Species | Gene Therapy | Genetically Modified Food | Stem Cell Research | Whales and Whaling |
|||||||||||||||||||||
|
|||||||||||||||||||||
|
|||||||||||||||||||||